Genomic Health(美國)

Genomic Health

美國GenomicHealthwww.genomichealth.com美國癌癥分子診斷市場第二大廠為GenomicHealth約占美國癌癥分子診斷市場27.7%，且?guī)缀跬耆珌碜匀橄侔┦袌?，它的OncotypeDXR.測試在早期乳腺癌病人中，能預(yù)測乳腺癌的續(xù)發(fā)可能性以及化療的效果，該公司以產(chǎn)品的差異化戰(zhàn)略取得了市場顯著的突破。GenomicHealth,alifesciencecompanyfou ndedinAugustof2000andlocatedinRedwoodCity,California,iscommittedtoimprovingthequalityofcancertreatmentdecisionsthroughtheresearch,developmentandcommercializationofgenomic-basedclinicallaboratoryservices.Tothatend,thecompanyconductssophisticatedgenomicresearchtodevelopclinically-validatedmoleculardiagnosticswhichprovideindividualizedinformationonresponsetocertaintypesoftherapy,aswellasthelikelihoodofdiseaserecurrence.Thesediagnostictechnologiesgenerateinformationthathealthcareprovidersandpatientscanuseinmakingtreatmentdecisions.ThepioneeringworkofGenomicHealthinmoleculardiagnosticshasledtotheOncotypeDXBreastCancerAssay,alaboratorytestthatanalyze